Abstract
The molecular characterization of Hereditary Spastic Paraplegias (HSP) and inherited cerebellar ataxias (CA) is challenged by their clinical and molecular heterogeneity. The recent application of NGS technologies is increasing the diagnostic rate, which can be also influenced by patients' selection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have